Literature DB >> 8626248

Himastatin, a new antitumor antibiotic from Streptomyces hygroscopicus. III. Structural elucidation.

J E Leet1, D R Schroeder, J Golik, J A Matson, T W Doyle, K S Lam, S E Hill, M S Lee, J L Whitney, B S Krishnan.   

Abstract

The structure of the antitumor antibiotic himastatin was determined using a combination of spectroscopic and chemical degradation techniques. Himastatin is a unique dimeric cyclohexadepsipeptide joined through a biphenyl linkage between two oxidized tryptophan units. The gross structure of the dimer was established through degradative ozonolysis. Himastatin consists of D-valine, D-threonine, L-leucine, L-alpha-hydroxyisovaleric acid, (3R,5R)-5-hydroxypiperazic acid, and (2R,3aR,8aR)-3a-hydroxyhexahydropyrrolo[2,3b]indole 2-carboxylic acid subunits.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626248     DOI: 10.7164/antibiotics.49.299

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

Review 1.  Heteroatom-Heteroatom Bond Formation in Natural Product Biosynthesis.

Authors:  Abraham J Waldman; Tai L Ng; Peng Wang; Emily P Balskus
Journal:  Chem Rev       Date:  2017-04-04       Impact factor: 60.622

2.  Biosynthesis of piperazic acid via N5-hydroxy-ornithine in Kutzneria spp. 744.

Authors:  Christopher S Neumann; Wei Jiang; John R Heemstra; Erin A Gontang; Roberto Kolter; Christopher T Walsh
Journal:  Chembiochem       Date:  2012-04-20       Impact factor: 3.164

3.  Total synthesis of himastatin.

Authors:  Kyan A D'Angelo; Carly K Schissel; Bradley L Pentelute; Mohammad Movassaghi
Journal:  Science       Date:  2022-02-24       Impact factor: 63.714

Review 4.  Promising bioactive compounds from the marine environment and their potential effects on various diseases.

Authors:  Akash Karthikeyan; Abey Joseph; Baiju G Nair
Journal:  J Genet Eng Biotechnol       Date:  2022-01-26

5.  Genome insights into the pharmaceutical and plant growth promoting features of the novel species Nocardia alni sp. nov.

Authors:  Imen Nouioui; Sung-Min Ha; Inwoo Baek; Jongsik Chun; Michael Goodfellow
Journal:  BMC Genomics       Date:  2022-01-21       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.